These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 35247517)
1. Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases. Zeller J; Bogner B; McFadyen JD; Kiefer J; Braig D; Pietersz G; Krippner G; Nero TL; Morton CJ; Shing KSCT; Parker MW; Peter K; Eisenhardt SU Pharmacol Ther; 2022 Jul; 235():108165. PubMed ID: 35247517 [TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: how conformational changes influence inflammatory properties. Eisenhardt SU; Thiele JR; Bannasch H; Stark GB; Peter K Cell Cycle; 2009 Dec; 8(23):3885-92. PubMed ID: 19887916 [TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and inflammation: conformational changes affect function. Wu Y; Potempa LA; El Kebir D; Filep JG Biol Chem; 2015 Nov; 396(11):1181-97. PubMed ID: 26040008 [TBL] [Abstract][Full Text] [Related]
4. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury. Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU Front Immunol; 2018; 9():675. PubMed ID: 29713320 [TBL] [Abstract][Full Text] [Related]
5. Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. McFadyen JD; Kiefer J; Braig D; Loseff-Silver J; Potempa LA; Eisenhardt SU; Peter K Front Immunol; 2018; 9():1351. PubMed ID: 29946323 [TBL] [Abstract][Full Text] [Related]
6. C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond. McFadyen JD; Zeller J; Potempa LA; Pietersz GA; Eisenhardt SU; Peter K Subcell Biochem; 2020; 94():499-520. PubMed ID: 32189313 [TBL] [Abstract][Full Text] [Related]
7. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects. Olson ME; Hornick MG; Stefanski A; Albanna HR; Gjoni A; Hall GD; Hart PC; Rajab IM; Potempa LA Front Immunol; 2023; 14():1264383. PubMed ID: 37781355 [TBL] [Abstract][Full Text] [Related]
8. Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes. Thiele JR; Zeller J; Bannasch H; Stark GB; Peter K; Eisenhardt SU Mediators Inflamm; 2015; 2015():372432. PubMed ID: 26089599 [TBL] [Abstract][Full Text] [Related]
9. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972 [TBL] [Abstract][Full Text] [Related]
10. Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Eisenhardt SU; Habersberger J; Peter K Trends Cardiovasc Med; 2009 Oct; 19(7):232-7. PubMed ID: 20382347 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP. Wang MS; Black JC; Knowles MK; Reed SM Anal Bioanal Chem; 2011 Sep; 401(4):1309-18. PubMed ID: 21725632 [TBL] [Abstract][Full Text] [Related]
13. The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action. Fujita M; Takada YK; Izumiya Y; Takada Y PLoS One; 2014; 9(4):e93738. PubMed ID: 24695572 [TBL] [Abstract][Full Text] [Related]
14. C-Reactive Protein in Atherosclerosis-More than a Biomarker, but not Just a Culprit. Kirkgöz K Rev Cardiovasc Med; 2023 Oct; 24(10):297. PubMed ID: 39077585 [TBL] [Abstract][Full Text] [Related]
15. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity. Ullah N; Wu Y Cell Biochem Biophys; 2022 Dec; 80(4):595-608. PubMed ID: 35997934 [TBL] [Abstract][Full Text] [Related]
16. Fueling the flames of colon cancer - does CRP play a direct pro-inflammatory role? Køstner AH; Fuglestad AJ; Georgsen JB; Nielsen PS; Christensen KB; Zibrandtsen H; Parner ET; Rajab IM; Potempa LA; Steiniche T; Kersten C Front Immunol; 2023; 14():1170443. PubMed ID: 37006231 [TBL] [Abstract][Full Text] [Related]
17. How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression. Rajab IM; Hart PC; Potempa LA Front Immunol; 2020; 11():2126. PubMed ID: 33013897 [TBL] [Abstract][Full Text] [Related]
18. C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms. Potempa LA; Rajab IM; Olson ME; Hart PC Front Immunol; 2021; 12():744129. PubMed ID: 34552600 [TBL] [Abstract][Full Text] [Related]